Αρχειοθήκη ιστολογίου

Πέμπτη 20 Ιουλίου 2017

Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA

The NDA contains data to support approval for YONSA, (abiraterone acetate) ultramicrosize tablets, for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Churchill Pharmaceuticals also announces positive results from the pivotal ST... Biopharmaceuticals, Oncology, FDA Churchill Pharmaceuticals, YONSA, abiraterone, Prostate Cancer (Source: HSMN NewsFeed)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uDZS0J
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader